Summary
Eli Lilly and Company (LLY) filed an 8-K report on October 23, 2014, to announce its financial results for the third quarter and the nine-month period ended September 30, 2014. The report indicates that the company issued a press release and held a teleconference to discuss these results. Investors should note that Lilly utilizes non-GAAP financial measures, such as non-GAAP net income and earnings per share, alongside GAAP figures. The company believes these non-GAAP measures offer a clearer view of ongoing operations and aid in meaningful period-over-period comparisons by excluding items that are highly variable and difficult to predict, thereby preventing distortion of reported operations.
Key Highlights
- 1Announcement of Q3 2014 and nine-month period financial results.
- 2The company held a teleconference and webcast to discuss results with analysts and media.
- 3Use of non-GAAP financial measures (e.g., non-GAAP net income and EPS) is highlighted.
- 4Lilly states non-GAAP measures help investors evaluate ongoing operations and identify operating trends.
- 5Non-GAAP measures are presented to assist in meaningful period-over-period comparisons.
- 6Management uses non-GAAP measures internally for performance evaluation and resource allocation.
- 7The information furnished is not deemed 'filed' for Section 18 purposes.